TrialCirculation2017

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).

Amit V Khera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.